CANDACE CHAFTON: Open Payments
NPI 1497285159 · ROLLA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 26 payments from 8 companies in 2025. Trend: 2023 $210 · 2024 $1,582 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 7 | $410 |
| GlaxoSmithKline, LLC. | 8 | $209 |
| Regeneron Healthcare Solutions, Inc. | 2 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| GENZYME CORPORATION | 1 | $14 |
Products named: INSPIRE, NUCALA, DUPIXENT, TEZSPIRE, FASENRA, NEFFY, ZORYVE.
Industry payments across MO — which companies pay providers there.
